Protara Therapeutics Newsroom

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)

TipRanksSep 12 07:30 ET · Ratings

Opaleye Management Inc. Reduces Stake in Protara Therapeutics Inc.

Yahoo FinanceSep 12 01:34 ET

TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating

Moomoo NewsSep 9 20:31 ET · Ratings

Protara Therapeutics Announces Results From THRIVE-1, A Study Evaluating The Prevalence Of Choline Deficiency And Liver Injury In Patients Dependent On Parenteral Support

BenzingaSep 9 08:09 ET

Express News | Protara Therapeutics Inc - Expects to Dose First Patient in Pivotal Pk Trial for IV Choline Chloride in Q1 2025

ReutersSep 9 08:07 ET

Express News | Protara Therapeutics Inc - Announces Results From Thrive-1

ReutersSep 9 08:07 ET

Express News | Protara Therapeutics Inc - Enrollment in Additional Cohorts Underway With Initial Results Expected in 1H'25

ReutersSep 9 08:05 ET

Express News | Protara Therapeutics Inc - Tara-002 Demonstrated Compelling Efficacy and Was Generally Well-Tolerated

ReutersSep 9 08:05 ET

Express News | Protara Therapeutics Announces Completion of First Cohort in Phase 2 Starborn-1 Trial of Tara-002 in Pediatric Patients With Lymphatic Malformations

ReutersSep 9 08:05 ET

Protara Therapeutics Announces Results From THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support

Yahoo FinanceSep 9 08:00 ET

Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Yahoo FinanceSep 3 08:00 ET

Protara Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesAug 12 09:53 ET

Express News | Protara Therapeutics : Oppenheimer Cuts Target Price to $25 From $30

ReutersAug 12 08:18 ET

Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

BenzingaAug 8 07:26 ET

Protara Therapeutics Analyst Ratings

BenzingaAug 8 07:24 ET · Ratings

Express News | Protara Therapeutics Inc : Guggenheim Cuts Target Price to $20 From $22

ReutersAug 7 06:47 ET

Protara Therapeutics | 10-Q: Q2 2024 Earnings Report

SECAug 6 08:13 ET · Announcements

Express News | Protara Therapeutics: Current Cash Resources Expected to Fund Operations Into 2026

ReutersAug 6 08:04 ET

Express News | Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update

ReutersAug 6 08:00 ET

Express News | Protara Therapeutics Q2 Net Income USD -9.513 Million

ReutersAug 6 08:00 ET